Pharmacists in Poquoson, VA Accepting Medicare

9 Pharmacists found. Showing 1 - 9

Mr. David Rice Creecy V, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 498 Wythe Creek Rd, Poquoson, VA 23662 Phone: 757-868-7114    Fax: 757-868-7922

Dr. Shannon Alston, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 498 Wythe Creek Rd, Poquoson, VA 23662 Phone: 757-868-7114

Robyn Progar, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 421 Wythe Creek Rd, Poquoson, VA 23662 Phone: 757-868-0297

Mrs. Elizabeth Kay Crispen, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 421 Wythe Creek Rd, Poquoson, VA 23662 Phone: 757-868-0297

Jeffrey Watson Alston, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 421 Wythe Creek Rd, Poquoson, VA 23662 Phone: 757-868-0297

Mrs. Debra Hedge Cody Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 498 Wythe Creek Rd, Poquoson, VA 23662 Phone: 757-868-7114    Fax: 757-868-7922

Whitney Jean Brunet, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 452 Wythe Creek Rd, Poquoson, VA 23662 Phone: 757-231-2001

Mr. Douglas Coventry Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 498 Wythe Creek Rd, Poquoson, VA 23662 Phone: 757-868-9261    Fax: 757-868-7922

Dr. Dajana Srbljan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 421 Wythe Creek Rd, Poquoson, VA 23662 Phone: 757-868-0297

News Archive

The Immortality Project awards $2.3M to study near-death experiences, beliefs in afterlife

Phenomena related to near-death experiences, immortality in virtual reality, and genes that prevent a species of freshwater hydra from aging are among the first research proposals funded by The Immortality Project at the University of California, Riverside.

Novel cardiac pump shows superior outcomes in patients with advanced heart failure

Severely ill patients with advanced heart failure who received a novel heart pump—the HeartMate 3 left ventricular assist device— suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

ANIS2's second edition on ‘micro and nanotechnologies for cancer research' is open for registrations

There is still time until January 8 2010 to register for the second edition of the Alp NanoBio International School (ANIS2), which will be held in Sterzing/Vipiteno (Bozen, Italy) from 11 to 15 of January 2010, organized by the Centre of Excellence LATEMAR - funded by MIUR, in collaboration with the Fondazione Bruno Kessler (FBK).

Taiho Pharmaceutical receives approval to market ABRAXANE IV Infusion 100 mg in Japan

Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.

Read more Medical News

› Verified 8 days ago